All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| ADMP / Adamis Pharmaceuticals Corp
|
|
|
|
|
|
|
|
| ECIA / Encision Inc.
|
|
|
|
|
|
|
|
| AMPE / Ampio Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| STXS / Stereotaxis, Inc.
|
|
|
|
|
|
|
|
| ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
| AVEO / AVEO Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BLFS / BioLife Solutions, Inc.
|
|
|
|
|
|
|
|
| US0906721065 / BioTelemetry, Inc.
|
|
|
|
|
|
|
|
| VXRT / Vaxart, Inc.
|
|
|
|
|
|
|
|
| US0909311062 / BioSpecifics Technologies Corp.
|
|
|
|
|
|
|
|
| DXTR / Dextera Surgical Inc.
|
|
|
|
|
|
|
|
| CLTX / Celsus Therapeutics
|
|
|
|
|
|
|
|
| CEMI / Chembio Diagnostics Inc.
|
|
|
|
|
|
|
|
| CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
| CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
| CUTR / Cutera, Inc.
|
|
|
|
|
|
|
|
| CYTR / LadRx Corp
|
|
|
|
|
|
|
|
| DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
| WINT / Windtree Therapeutics, Inc.
|
|
|
|
|
|
|
|
| EXAC / Exactech, Inc.
|
|
|
|
|
|
|
|
| FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GNVC / GenVec, Inc.
|
|
|
|
|
|
|
|
| IMUC / EOM Pharmaceuticals Holdings, Inc.
|
|
|
|
|
|
|
|
| NSPR / InspireMD, Inc.
|
|
|
|
|
|
|
|
| 45784PAD3 / Insulet Corp. Bond
|
|
|
|
|
|
|
|
| ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
| KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
| MACK / Merrimack Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NWBO / Northwest Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
|
|
|
|
|
|
| 670704AC9 / NuVasive, Inc. Bond
|
|
|
|
|
|
|
|
| NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
| OCRX / Ocera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
| PCYC / Pharmacyclics
|
|
|
|
|
|
|
|
| PLX / Protalix BioTherapeutics, Inc.
|
|
|
|
|
|
|
|
| US74975N1054 / RTI Surgical, Inc.
|
|
|
|
|
|
|
|
| REGADO BIOSCIENCES INC
/ (75874Q107) |
|
|
|
|
|
|
|
| RVP / Retractable Technologies, Inc.
|
|
|
|
|
|
|
|
| SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
| SPNC / Spectranetics Corp. (The)
|
|
|
|
|
|
|
|
| MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
| TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
|
|
|
|
|
| UPI / Uroplasty Inc
|
|
|
|
|
|
|
|
| RIOT / Riot Platforms, Inc.
|
|
|
|
|
|
|
|
| XNPT / XenoPort, Inc.
|
|
|
|
|
|
|
|
| ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
|
|
|
|
|
| GLMD / Galmed Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
| LMNS / Lumenis Ltd
|
|
|
|
|
|
|
|
| ELOS / Syneron Medical Ltd.
|
|
|
|
|
|
|
|
| PODD / Insulet Corporation
|
|
|
|
|
|
|
|
| ATRC / AtriCure, Inc.
|
|
|
|
|
|
|
|
